Berea Health And Rehabilitation | |
601 Richmond Road, Berea, Kentucky 40403 | |
(859) 986-4710 | |
Name | Berea Health And Rehabilitation |
---|---|
Location | 601 Richmond Road, Berea, Kentucky |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 84 |
Occupancy Rate | 66.19% |
Medicare ID (CCN) | 185384 |
Legal Business Name | Berea Healthcare Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1336178623 |
Organization Name | BEREA HEALTH CARE, INC. |
Address | 601 Richmond Rd N, Berea, KY 40403 |
Phone Number | 859-623-0898 |
News Archive
Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).
New research conducted in adolescent rodents provides insights on the mechanisms behind anorexia nervosa and points to a potential treatment strategy.
Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.
A new study from University of Kentucky Markey Cancer researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.
NeuroTherapeutics Pharma, Inc. (NTP), a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, announced today that it closed a $43 million Series B financing. New investors include Fidelity Biosciences, MPM Capital and SR One, who co-led the transaction, and Pfizer, Inc. Existing investors Novo Ventures and Thomas McNerney & Partners also participated in the round.
› Verified 6 days ago
NPI Number | 1619487741 |
Organization Name | BEREA HEALTHCARE, LLC |
Doing Business As | BEREA ACQUISITION, LLC |
Address | 601 Richmond Rd N, Berea, KY 40403 |
Phone Number | 859-623-0898 |
News Archive
Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).
New research conducted in adolescent rodents provides insights on the mechanisms behind anorexia nervosa and points to a potential treatment strategy.
Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.
A new study from University of Kentucky Markey Cancer researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.
NeuroTherapeutics Pharma, Inc. (NTP), a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, announced today that it closed a $43 million Series B financing. New investors include Fidelity Biosciences, MPM Capital and SR One, who co-led the transaction, and Pfizer, Inc. Existing investors Novo Ventures and Thomas McNerney & Partners also participated in the round.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).
New research conducted in adolescent rodents provides insights on the mechanisms behind anorexia nervosa and points to a potential treatment strategy.
Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.
A new study from University of Kentucky Markey Cancer researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.
NeuroTherapeutics Pharma, Inc. (NTP), a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, announced today that it closed a $43 million Series B financing. New investors include Fidelity Biosciences, MPM Capital and SR One, who co-led the transaction, and Pfizer, Inc. Existing investors Novo Ventures and Thomas McNerney & Partners also participated in the round.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $206560 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 16 | 14.46 |
Percentage of long-stay residents who lose too much weight | 14.69 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 46.25 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.83 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 5.12 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 7.58 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.42 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.6 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 31.54 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 88.07 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.74 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 16.24 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 32.24 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 12.43 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.66 | 95.98 |
Percentage of short-stay residents who made improvements in function | 63.28 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 95.68 | 82.93 |
News Archive
Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).
New research conducted in adolescent rodents provides insights on the mechanisms behind anorexia nervosa and points to a potential treatment strategy.
Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.
A new study from University of Kentucky Markey Cancer researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.
NeuroTherapeutics Pharma, Inc. (NTP), a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, announced today that it closed a $43 million Series B financing. New investors include Fidelity Biosciences, MPM Capital and SR One, who co-led the transaction, and Pfizer, Inc. Existing investors Novo Ventures and Thomas McNerney & Partners also participated in the round.
› Verified 6 days ago
The Terrace Nursing And Rehabilitation Center Location: 1043 Brooklyn Boulevard, Berea, Kentucky 40403 Phone: (859) 228-0551 | |
Berea Health And Rehabilitation Location: 601 Richmond Road, Berea, Kentucky 40403 Phone: (859) 986-4710 |